Search

Your search keyword '"Niida, Shumpei"' showing total 521 results

Search Constraints

Start Over You searched for: Author "Niida, Shumpei" Remove constraint Author: "Niida, Shumpei"
521 results on '"Niida, Shumpei"'

Search Results

1. Population-specific putative causal variants shape quantitative traits

3. Plasma biomarkers of neurodegeneration in patients and high risk subjects with Lewy body disease

10. A homozygous structural variant of RPGRIP1 is frequently associated with achromatopsia in Japanese patients with IRD

17. Molecular subtypes of lung adenocarcinoma present distinct immune tumor microenvironments

19. A homozygous structural variant of RPGRIP1 is frequently associated with achromatopsia in Japanese patients with IRD

22. The HLA-DRB1*09:01-DQB1*03:03 haplotype is associated with the risk for late-onset Alzheimer’s disease in APOE $${{\varepsilon }}$$4–negative Japanese adults

23. Exploring the genetic diversity of the Japanese population: Insights from a large-scale whole genome sequencing analysis

24. Plasma biomarkers of neurodegeneration in patients with Parkinson’s disease and dementia with Lewy bodies and at-risk individuals of Lewy body disease in the NaT-PROBE cohort

27. Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases

28. Trends in Pharmaceutical Research and Development Vol. 6

30. Transferability of a European-derived Alzheimer’s Disease Genetic Risk Score across Multi-Ancestry Populations

31. Polygenic effects on the risk of Alzheimer′s disease in the Japanese population

35. FIGURE 5 from Tumor-infiltrating Leukocyte Profiling Defines Three Immune Subtypes of NSCLC with Distinct Signaling Pathways and Genetic Alterations

36. Table S3 from Tumor-infiltrating Leukocyte Profiling Defines Three Immune Subtypes of NSCLC with Distinct Signaling Pathways and Genetic Alterations

37. FIGURE 3 from Tumor-infiltrating Leukocyte Profiling Defines Three Immune Subtypes of NSCLC with Distinct Signaling Pathways and Genetic Alterations

43. Tumor-infiltrating leukocyte profiling defines three immune subtypes of NSCLC with distinct signaling pathways and genetic alterations

44. Supplementary text from Large-scale Circulating microRNA Profiling for the Liquid Biopsy of Prostate Cancer

45. Figure S1-3, Table S1-4 from Large-scale Circulating microRNA Profiling for the Liquid Biopsy of Prostate Cancer

46. Data from Hyaluronan Deficiency in Tumor Stroma Impairs Macrophage Trafficking and Tumor Neovascularization

47. Supplementary Figure 2 from Hyaluronan Deficiency in Tumor Stroma Impairs Macrophage Trafficking and Tumor Neovascularization

48. Supplementary Figure 3 from Hyaluronan Deficiency in Tumor Stroma Impairs Macrophage Trafficking and Tumor Neovascularization

49. Supplementary Methods, Figure Legends 1-3 from Hyaluronan Deficiency in Tumor Stroma Impairs Macrophage Trafficking and Tumor Neovascularization

50. Supplementary Figure 1 from Hyaluronan Deficiency in Tumor Stroma Impairs Macrophage Trafficking and Tumor Neovascularization

Catalog

Books, media, physical & digital resources